The intervention of macrophages in progressive fibrosis characterizing systemic sclerosis: A systematic review
Autoimmunity Reviews,
Journal Year:
2024,
Volume and Issue:
23(10), P. 103637 - 103637
Published: Sept. 8, 2024
Language: Английский
Marine Phytoplankton Bioactive Lipids and Their Perspectives in Clinical Inflammation
Marine Drugs,
Journal Year:
2025,
Volume and Issue:
23(2), P. 86 - 86
Published: Feb. 17, 2025
Marine
phytoplankton
is
an
emerging
source
of
immunomodulatory
bioactive
lipids
(BLs).
Under
physiological
growth
conditions
and
upon
stress
challenges,
several
eukaryotic
microalgal
species
accumulate
lipid
metabolites
that
resemble
the
precursors
animal
mediators
inflammation:
eicosanoids
prostaglandins.
Therefore,
marine
could
serve
as
a
biotechnological
platform
to
produce
functional
BLs
with
therapeutic
applications
in
management
chronic
inflammatory
diseases
other
clinical
conditions.
However,
be
commercially
competitive,
lipidic
precursor
yields
should
enhanced.
Beside
tailoring
cultivation
native
producers,
genetic
engineering
feasible
strategy
accrue
production
introduce
heterologous
biosynthetic
pathways
hosts.
Here,
we
present
state-of-the-art
research
on
from
discuss
synthetic
biology
approaches
boost
their
light-driven
biosynthesis.
Language: Английский
Talaroterpenoids A–F: Six New Seco-Terpenoids from the Marine-Derived Fungus Talaromyces aurantiacus
Zhongli Peng,
No information about this author
Hui Jia,
No information about this author
Yan-Liang Luo
No information about this author
et al.
Marine Drugs,
Journal Year:
2024,
Volume and Issue:
22(10), P. 475 - 475
Published: Oct. 18, 2024
Six
new
highly
oxidized
seco-terpenoids,
including
three
3-nor-labdane
type
diterpenes,
talaroterpenoids
A–C
(1–3),
and
meroterpenoids
containing
an
orthoester
group,
D–F
(6–8),
together
with
five
known
compounds
(4–5
9–11),
were
isolated
from
the
marine-derived
fungus
Talaromyces
aurantiacus.
Their
chemical
structures
elucidated
through
1D,
2D
NMR,
HRESIMS,
J-based
configuration
analysis
(JBCA),
computational
ECD
calculations,
single-crystal
X-ray
diffraction
analysis.
Compounds
1
2
contain
unusual
6,20-γ-lactone-bridged
scaffold.
10
11
presented
inhibitory
effects
on
NO
release
in
lipopolysaccharide
(LPS)-induced
BV-2
cells
IC50
values
of
11.47
11.32
μM,
respectively.
Talaroterpenoid
C
(3)
showed
moderate
antifungal
activity
against
A.
alternata
P.
theae
Steyaert.
Language: Английский
Recent Advances of the Zebrafish Model in the Discovery of Marine Bioactive Molecules
Changyu Liu,
No information about this author
Jiaxun Li,
No information about this author
Dexu Wang
No information about this author
et al.
Marine Drugs,
Journal Year:
2024,
Volume and Issue:
22(12), P. 540 - 540
Published: Nov. 30, 2024
Marine
natural
products
are
increasingly
utilized
in
nutrition,
cosmetics,
and
medicine,
garnering
significant
attention
from
researchers
globally.
With
the
expansion
of
marine
resource
exploration
recent
years,
demand
for
has
risen,
necessitating
rapid
cost-effective
activity
evaluations
using
model
organisms.
Zebrafish,
a
valuable
vertebrate
model,
become
an
efficient
tool
screening
identifying
safe,
active
molecules
products.
This
review,
based
on
nearly
10
years
literature,
summarizes
current
status
progress
zebrafish
models
evaluating
product
bioactivity.
It
also
highlights
their
potential
exploring
resources
with
health
benefits,
offering
reference
future
development
utilization
biological
resources.
Language: Английский